Cathy Fernandez
Family · Dallas, TXNPI 1184262370
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 217 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 28.6% of the total. 2025 is the largest year on record at $1,908, 4.7 times the $402 reported in 2021. Among family clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 217 payments — averaging $20.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Amgen$925
- UCB, Inc.$551
- Lilly USA, LLC$258
- Sanofi$244
- Novartis$205
- plus $1K from 15 others
What the payments were for
- Food & beverage$4,504100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 66 | $1,287 |
| Amgen(2 entities) | 48 | $925 |
| UCB, Inc. | 20 | $551 |
| Lilly USA, LLC | 12 | $258 |
| Sanofi | 8 | $244 |
| Novartis | 10 | $205 |
| GSK | 10 | $200 |
| Johnson & Johnson | 8 | $148 |
| AstraZeneca | 7 | $133 |
| Mallinckrodt Hospital Products Inc. | 6 | $107 |
| E.r. Squibb & Sons, L.L.C. | 5 | $96 |
| Pfizer | 4 | $63 |
| Fresenius Kabi USA, LLC | 2 | $58 |
| Aurinia Pharma U.S., Inc. | 2 | $43 |
| ANI Pharmaceuticals, Inc. | 2 | $42 |
| Hospira, Inc. | 2 | $38 |
| Boehringer Ingelheim | 1 | $26 |
| Octapharma USA, Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $23 |
| Kyowa Kirin, Inc. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $15 |
How this compares
$4,504 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 29 | $802 |
| MethotrexateMethotrexate Sodium | 19 | $608 |
| Prednisone | 23 | $196 |
Paid to pharmacies, not to this prescriber.
Other family in Dallas
- David WeirDallas$959K
- Sie ThomasDallas$197K
- Marcia HarrisDallas$156K
- Miles HortonDallas$72K
- Natasha SimmonsDallas$38K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.